Literature DB >> 8051740

Activation of urinary kallikrein in patients with interstitial cystitis.

B L Zuraw1, S Sugimoto, C L Parsons, T Hugli, M Lotz, J Koziol.   

Abstract

A potential pathophysiological role for the urinary kallikrein-kinin system is suggested by the prominent symptoms of bladder pain and urinary frequency in interstitial cystitis. Kallikrein activity in the urine of 84 patients with interstitial cystitis and 33 normal volunteers was determined by cleavage of the synthetic substrate Val-Leu-Arg-pNA. Interstitial cystitis patients had significantly higher levels of kallikrein activity than did the normal volunteers. Kallikrein activity was correlated with symptoms of bladder pain and voiding frequency. The percentage of total urinary kallikrein in the active form correlated with active kallikrein levels and was also increased in interstitial cystitis patients, particularly those with higher levels of pain. Patients who underwent hydrodistention and subsequently experienced relief from the bladder symptoms had a decrease in urinary kallikrein levels, whereas patients who failed to improve following hydrodistention did not.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8051740     DOI: 10.1016/s0022-5347(17)32595-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  4 in total

1.  Changes in urine markers and symptoms after bladder distention for interstitial cystitis.

Authors:  Deborah R Erickson; Allen R Kunselman; Christina M Bentley; Kenneth M Peters; Eric S Rovner; Laurence M Demers; Marcia A Wheeler; Susan K Keay
Journal:  J Urol       Date:  2007-02       Impact factor: 7.450

Review 2.  Interstitial cystitis.

Authors:  D R Erickson; M F Davies
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  1998

3.  Pharmacological and molecular evidence for kinin B1 receptor expression in urinary bladder of cyclophosphamide-treated rats.

Authors:  P Belichard; J M Luccarini; E Defrêne; P Faye; R M Franck; H Duclos; J L Paquet; D Pruneau
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

4.  Peptidomics analysis reveals changes in small urinary peptides in patients with interstitial cystitis/bladder pain syndrome.

Authors:  Md Shadman Ridwan Abid; Haowen Qiu; Bridget A Tripp; Aline de Lima Leite; Heidi E Roth; Jiri Adamec; Robert Powers; James W Checco
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.